Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Financial planning is vital for a successful retirement. Discover the reasons why it matters for your long-term financial health.
24,228 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Intel and AMD slid on Friday as AI competition intensifies and supply-chain tensions weigh on the sector, despite str...
CrossCountry Mortgage enters the race to acquire Two Harbors, joining a competing all cash bid and heightening a batt...
A tiny $3.7 million exit can mask broader gains in regional bank stocks. This article breaks down what that signal re...
A data storage chief explains why AI returns vary by use case and shares concrete examples of where investments pay o...
Elon Musk is stirring the pot once again with Terafab, the newest idea from elon that aims to redefine manufacturing ...
Nearly half of U.S. homeowners paused moving plans in the last year, a sign that housing market inertia grows even as...
Teads released its Q1 2026 results, showing resilience in a volatile ad market. This investor-focused guide breaks do...
Telos (TLS) 2026 earnings outlook is shaping up as multiple revenue streams converge—from on-chain activity fees to s...
SpaceX could become one of the biggest IPOs in history. This guide breaks down what to watch, what it means for your ...
Ford surprised markets with an upward revision to its 2026 guidance after a solid first quarter. This article breaks ...
A global CEO survey shows a shift away from junior roles as companies deploy AI. The move, echoed by Harvard findings...